Trials / Completed
CompletedNCT00888290
Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Albert Einstein College of Medicine · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This study will enroll 25 patients with kidney disease to evaluate the effects of different doses of sodium bicarbonate (baking soda) on levels of bicarbonate in the blood, kidney function and muscle strength. The investigators will also evaluate safety and tolerability of different doses.
Detailed description
This study enrolled 20 patient to evaluate the effects of different doses of sodium bicarbonate. We will test serum bicarbonate levels, potassium levels and muscle function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium bicarbonate | Sodium bicarbonate at 3 different doses or placebo. The different doses tested will be: 0.3 mEq/kg of ideal body weight, 0.6 mEq/kg of ideal body weight and 1 mEq/kg pf ideal body weight |
| DRUG | Placebos | Placebo at 3 different doses to match Sodium bicarbonate dosing |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-05-01
- Completion
- 2010-05-01
- First posted
- 2009-04-27
- Last updated
- 2022-08-30
- Results posted
- 2022-08-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00888290. Inclusion in this directory is not an endorsement.